Test group 1

DRUG2 trials

Sponsors

Hanlim Pharm. Co., Ltd.

Conditions

Diabete Type 2Hypertension

Phase 1

Clinical Trial to Evaluate the Pharmacokinetics and Safety Between the Single Administration of HL1113 and the Concomitant Administration of HL1113R1 and HL1113R2 for Healthy Subjects in Fasting State

CompletedNCT07568652

Hanlim Pharm. Co., Ltd.Diabete Type 2, Hypertension

Start: 2024-10-16End: 2024-11-15Updated: 2026-05-18

Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of HL1113-R1 and HL1113-R2 in Healthy Adult Volunteers

CompletedNCT07598968

Hanlim Pharm. Co., Ltd.Diabete Type 2, Hypertension

Start: 2023-06-18End: 2023-07-12Updated: 2026-05-20